Overview


According to FutureWise analysis the market for Immunoassay Interference Blocker in 2023 is US$ 0.27 billion, and is expected to reach US$ 0.43 billion by 2031 at a CAGR of 6.32%.

Growing prevalence of chronic diseases and increasing aging population across the globe are expected to increase demand for biochemical testing, as well as for immunoassay interference blocker kits and reagents due to increased adoption of these tools. In the near future, immunoassay interference blocker market growth could be significant due to its wide application across various immunoassay tests and diagnostic assays, as well as the collaborative research and development between researchers and manufacturers to develop and introduce newer and more efficient immunoassay interference blockers. Immunoassay interference blockers, such as antibody interference blockers, detection interference blockers, and surface interference blockers, have gained popularity over the last two decades. As molecular technologies emerge to diagnose infectious diseases at the point of care or treat diseases such as cancer, all-new technological innovations such as chips and microarrays, fluorescent in-situ hybridization, antibody capture assays, competitive ELISA, sandwich immunoassays, and sequencing are generating growth in the market for immunoassay interference blockers.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Immunoassay Interference Blocker Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Immunoassay Interference Blocker Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Abcam plc
  • AMS Biotechnology Limited
  • Aviva Systems Biology Corporation
  • Bio-Rad Laboratories, Inc
  • Meridian Bioscience, Inc
  • Roche Diagnostics GmbH
  • Rockland Immunochemicals, Inc.
  • Scantibodies Laboratory, Inc
  • Thermo Fisher Scientific Inc
  • Sysmex Corporation
  • Qiagen N.V.

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product

  • Antibody Interference Blockers
    • Human Serum Derived Blockers
    • Animal Serum Derived Blockers
    • Human Immunoglobulin Blockers
    • Animal Monoclonal Antibody IgG Blockers
    • Animal Polyclonal Antibody IgG Blockers
    • Heterophile Blocking Reagents
    • Others
  • Detection Interference Blockers
    • Enzyme Blockers
    • Alkaline Phosphate Blockers
    • β-Galactosidase Blockers
    • Others
  • Surface Interference Blockers
    • Bovine Serum Albumin Blockers
    • BSA Fraction V Blockers
    • Poly BSA Blockers
    • Solid Phase Blocking Buffers
    • Polymeric Blockers

By Application

  • Sandwich Immunoassay
  • Antibody Capture Assays
  • Competitive ELISA
  • Others

By End User

  • Biotechnology Companies
  • Contract Research Organisations
  • Academic and Research Institutes
  • Molecular Diagnostics Companies

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Immunoassay Interference Blocker Market By Product, By Application, By End User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Immunoassay Interference Blocker Market Variables, Trends and Scope

    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Immunoassay Interference Blocker Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Immunoassay Interference Blocker Market Analysis Tools and Scope

    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies

  • 7.   Immunoassay Interference Blocker Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Antibody Interference Blockers
         1.1. Human Serum Derived Blockers
         1.2. Animal Serum Derived Blockers
         1.3. Human Immunoglobulin Blockers
         1.4. Animal Monoclonal Antibody IgG Blockers
         1.5. Animal Polyclonal Antibody IgG Blockers
         1.6. Heterophile Blocking Reagents
         1.7. Others
        2. Detection Interference Blockers
         2.1. Enzyme Blockers
         2.2. Alkaline Phosphate Blockers
         2.3. β-Galactosidase Blockers
         2.4. Others
        3. Surface Interference Blockers
         3.1. Bovine Serum Albumin Blockers
         3.2. BSA Fraction V Blockers
         3.3. Poly BSA Blockers
         3.4. Solid Phase Blocking Buffers
         3.5 Polymeric Blockers

  • 8.   Immunoassay Interference Blocker Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Sandwich Immunoassay
        2. Antibody Capture Assays
        3. Competitive ELISA
        4. Others

  • 9.   Immunoassay Interference Blocker Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Biotechnology Companies
        2. Contract Research Organisations
        3. Academic and Research Institutes
        4. Molecular Diagnostics Companies

  • 10.   North America Immunoassay Interference Blocker Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Immunoassay Interference Blocker Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Immunoassay Interference Blocker Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Immunoassay Interference Blocker Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

    •   1. Abcam plc
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. AMS Biotechnology Limited
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Aviva Systems Biology Corporation
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Bio-Rad Laboratories, Inc
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Meridian Bioscience, Inc
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Roche Diagnostics GmbH
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Rockland Immunochemicals, Inc.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Scantibodies Laboratory, Inc
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Thermo Fisher Scientific Inc
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
         10. Sysmex Corporation
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Qiagen N.V.
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client

Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11